Expression of Chr9p21 genes CDKN2B (p15), CDKN2A (p16, p14) and MTAP in human atherosclerotic plaque
Authors:
- Kristina SassKSKristina Sass
- Gábor GäbelGGGábor Gäbel
- Hendrik BergertHBHendrik Bergert
- Joachim ThieryJTJoachim Thiery
- Daniel TeupserDTDaniel Teupser
- 1 February 2011
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 214 (2) , 264-270
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL ExpressionPLOS Genetics, 2010
- Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in miceNature, 2010
- Relationship between CAD Risk Genotype in the Chromosome 9p21 Locus and Gene Expression. Identification of Eight New ANRIL Splice VariantsPLOS ONE, 2009
- INK4/ARF Transcript Expression Is Associated with Chromosome 9p21 Variants Linked to AtherosclerosisPLOS ONE, 2009
- Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor‐α via the p38 mitogen‐activated protein kinase pathwayThe FASEB Journal, 2009
- Genomewide Association Analysis of Coronary Artery DiseaseNew England Journal of Medicine, 2007
- A Common Allele on Chromosome 9 Associated with Coronary Heart DiseaseScience, 2007
- Smad Expression in Human Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16Nature, 1995
- pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrestNature, 1994